A SYSTEMATIC REVIEW ON NANO DRUG DELIVERY SYSTEM: SOLID LIPID NANOPARTICLES (SLN)

SWAPNIL D. PHALAK; VISHAL BODKE; REENU YADAV; SATISH PANDAV; MALOJI RANAWARE

doi:10.22159/ijcpr.2024v16i1.4020

Authors

SWAPNIL D. PHALAK Department of Pharmaceutics, IES Institute of Pharmacy, IES University, Bhopal, Madhya Pradesh, India
VISHAL BODKE Department of Pharmaceutics, Konkan Gyanpeeth Rahul Dharkar College of Pharmacy and Research Institute, Karjat, Maharashtra, India
REENU YADAV IES Institute of Pharmacy, IES University, Bhopal, Madhya Pradesh, India
SATISH PANDAV Department of Pharmacology, Konkan Gyanpeeth Rahul Dharkar College of Pharmacy and Research Institute, Karjat, Maharashtra, India
MALOJI RANAWARE Department of Pharmacology, Konkan Gyanpeeth Rahul Dharkar College of Pharmacy and Research Institute, Karjat, Maharashtra, India

DOI:

https://doi.org/10.22159/ijcpr.2024v16i1.4020

Keywords:

Nanoparticles, Sold lipid nanoparticle, Liposomes, Carriers etc

Abstract

Nanomedicine along with nano-delivery systems, are a young but fast-emerging science in which tiny materials are used as diagnostic tools or to deliver therapeutic drugs to specific targeted locations in a controlled manner. Nanotechnology has numerous advantages in the treatment of chronic human diseases through the site-specific and target-oriented delivery of precise medications. There have recently been several notable applications of nanomedicine (chemotherapeutic agents, biological agents, immunotherapeutic agents, and so on) in the treatment of various disorders. Efficient use of pricey medications and excipients, as well as cost savings in manufacturing Beneficial to patients, improved therapy, comfort, and the standard of living. Lipids have been proposed as an alternate carrier to circumvent the constraints of polymeric nanoparticles, notably for lipophilic medicines. Such small particles of lipid are known as solid lipid nanoparticles (SLNs), and they are gaining popularity among formulators all over the world. SLNs are colloidal carriers that were developed in the last decade as a replacement for traditional carriers. Lipid nanoparticles have caught the interest of researchers during the last two decades and have shown considerable therapeutic success since the first clinical approval of Doxil in 1995. Simultaneously, lipid nanoparticles have shown significant promise in conveying nucleic acid medications, as proven by the approval of two RNA treatments and an mRNA COVID-19 vaccination.

Downloads

Download data is not yet available.

References

Nguyen TTL, Duong VA. Solid lipid nanoparticles. Encyclopedia. 2020;2(2):952-73. doi: 10.3390/encyclopedia2020063.

Madkhali OA. Perspectives and prospective on solid lipid nanoparticles as drug delivery systems. Molecules. 2022;27(5):1543. doi: 10.3390/molecules27051543, PMID 35268643.

Scioli Montoto S, Muraca G, Ruiz ME. Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects. Front Mol Biosci. 2020;7(Oct):587997. doi: 10.3389/fmolb.2020.587997, PMID 33195435.

Basha SK, Dhandayuthabani R, Muzammil MS, Kumari VS. Solid lipid nanoparticles for oral drug delivery. Mater Today Proc. 2021;36:313-24. doi: 10.1016/j.matpr.2020.04.109.

Garud A, Singh D, Garud N. Solid lipid nanoparticles (SLN): method, characterization and applications. Int Curr Pharm J. 2012;1(11, Oct):384-93. doi: 10.3329/icpj.v1i11.12065.

Rastegari E, Hsiao YJ, Lai WY, Lai YH, Yang TC, Chen SJ. An update on mesoporous silica nanoparticle applications in nanomedicine. Pharmaceutics. 2021;13(7):1067. doi: 10.3390/pharmaceutics13071067, PMID 34371758.

Mishra V, Bansal KK, Verma A, Yadav N, Thakur S, Sudhakar K. Solid lipid nanoparticles: emerging colloidal Nano drug delivery systems. Pharmaceutics. 2018;10(4):191. doi: 10.3390/pharmaceutics10040191, PMID 30340327.

De Jong. “Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008 Jun;S596:133. doi: 10.2147/IJN.

Perez Herrero E, Fernandez Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93(Jun):52-79. doi: 10.1016/j.ejpb.2015.03.018, PMID 25813885.

Garg NK, Tandel N, Jadon RS, Tyagi RK, Katare OP. Lipid–polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions. Drug Discov Today. 2018;23(9):1610-21. doi: 10.1016/j.drudis.2018.05.033, PMID 29857164.

Garud A, Singh D, Garud N. Solid lipid nanoparticles (SLN): method, characterization and applications. Int Curr Pharm J 2023;1(11):384-93. doi: 10.3329/icpj.v1i11.12065.

Raut ID, Doijad RC, Mohite SK. Solid lipid nanoparticles: a promising drug delivery system. Int J Pharm Sci Res. 2018;9(3):862-71. doi: 10.13040/IJPSR.0975-8232.9(3).862-71.

Deng Y, Zhang X, Shen H, He Q, Wu Z, Liao W. Application of the nano-drug delivery system in the treatment of cardiovascular diseases. Front Bioeng Biotechnol. 2019;7:489. doi: 10.3389/fbioe.2019.00489, PMID 32083068.

Naseri N, Valizadeh H, Zakeri Milani P. Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application. Adv Pharm Bull. 2015 Sep;5(3):305-13. doi: 10.15171/apb.2015.043, PMID 26504751.

Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol. 2018;9:1050-74. doi: 10.3762/bjnano.9.98, PMID 29719757.

Wesselinova D. Current major cancer targets for nanoparticle systems. Curr Cancer Drug Targets. 2011 Feb;11(2):164-83. doi: 10.2174/156800911794328484, PMID 21158716.

Kushwaha AK, Vuddanda PR, Karunanidhi P, Singh SK, Singh S. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. BioMed Res Int. 2013. doi: 10.1155/2013/584549, PMID 24228255.

Altammar KA. A review on nanoparticles: characteristics, synthesis, applications, and challenges. Front Microbiol. 2023;14:1155622. doi: 10.3389/fmicb.2023.1155622, PMID 37180257.

Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol. 2018 Apr 3;9:1050-74. doi: 10.3762/bjnano.9.98, PMID 29719757, PMCID PMC5905289.

Buzea C, Pacheco II, Robbie K, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007 Dec;2(4):MR17-71. doi: 10.1116/1.2815690, PMID 20419892.

Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez Torres MDP, Acosta Torres LS. Nano-based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16(1):71. doi: 10.1186/s12951-018-0392-8, PMID 30231877.

Khater D, Nsairat H, Odeh F, Saleh M, Jaber A, Alshaer W. Design, preparation, and characterization of effective dermal and transdermal lipid nanoparticles: a review. Cosmetics. 2021;8(2). doi: 10.3390/cosmetics8020039.

Noble GT, Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B. Ligand-targeted liposome design: challenges and fundamental considerations. Trends Biotechnol. 2014;32(1):32-45. doi: 10.1016/j.tibtech.2013.09.007, PMID 24210498.

Akbarzadeh A, Rezaei Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013 Feb 22;8(1):102. doi: 10.1186/1556-276X-8-102, PMID 23432972, PMCID PMC3599573.

Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022 Feb 17;27(4):1372. doi: 10.3390/molecules27041372, PMID 35209162, PMCID PMC8879473.

Genç L, Dikmen G, Guney Eskiler G. Formulation of nano drug delivery systems. J Mater Sci Eng A. 2011;1:132-7.

Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev. 2007 Jul 10;59(6):454-77. doi: 10.1016/j.addr.2007.04.011. PMID: 17570559.

De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3(2):133-49. doi: 10.2147/ijn.s596, PMID 18686775, PMCID PMC2527668.

Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arabian Journal of Chemistry. 2019;12(7):908-31. doi: 10.1016/j.arabjc.2017.05.011.

Mo K, Kim A, Choe S, Shin M, Yoon H. Overview of solid lipid nanoparticles in breast cancer therapy. Pharmaceutics. 2023;15(8):2065. doi: 10.3390/pharmaceutics15082065, PMID 37631279.

Geszke Moritz M, Moritz M. Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies. Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:982-94. doi: 10.1016/j.msec.2016.05.119, PMID: 27524099.

Manjunath K, Reddy JS, Venkateswarlu V. Solid lipid nanoparticles as drug delivery systems. Methods Find Exp Clin Pharmacol. 2005 Mar;27(2):127-44. doi: 10.1358/mf.2005.27.2.876286, PMID: 15834465.

Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):165-96. doi: 10.1016/s0169-409x(01)00105-3, PMID: 11311991.

Zur Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery–drug release and release mechanism. Eur J Pharm Biopharm. 1998;45(2):149-55. doi: 10.1016/s0939-6411(97)00150-1, PMID 9704911.

Sastri KT, Radha GV, Pidikiti S, Vajjhala P. Solid lipid nanoparticles: preparation techniques, their characterization, and an update on recent studies. J Appl Pharm Sci. 2020;10(6):126-41. doi: 10.7324/JAPS.2020.10617.

Xu L, Wang X, Liu Y, Yang G, Falconer RJ, Zhao C. Lipid nanoparticles for drug delivery. Advanced NanoBiomed Research. 2022;2(2):2100109. doi: 10.1002/anbr.202100109.

Plaza Oliver M, Santander Ortega MJ, Lozano MV. Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv Transl Res. 2021;11(2):471-97. doi: 10.1007/s13346-021-00908-7, PMID 33528830.

Viegas C, Patrício AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review. Pharmaceutics. 2023;15(6):1593. doi: 10.3390/pharmaceutics15061593, PMID 37376042.

Montasser I, Shahgaldian P, Perret F, Coleman AW. Solid lipid nanoparticle-based calix[n]arenes and Calix-resorcin arenes as building blocks: synthesis, formulation and characterization. Int J Mol Sci. 2013 Nov 5;14(11):21899-942. doi: 10.3390/ijms141121899, PMID: 24196356.

Parhi R, Suresh P. Preparation and characterization of solid lipid nanoparticles-a review. Curr Drug Discov Technol. 2012 Mar;9(1):2-16. doi: 10.2174/157016312799304552, PMID: 22235925.

Marcato PD, Duran N. New aspects of nanopharmaceutical delivery systems. J Nanosci Nanotechnol. 2008 May;8(5):2216-29. doi: 10.1166/jnn.2008.274, PMID: 18572633.

Patil P, Harak K, Saudagar R. THE solid lipid nanoparticles a review. JDDT. 2019 May 15;9(3):525-30.

Duan Y, Dhar A, Patel C, Khimani M, Neogi S, Sharma P. A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems. RSC Adv. 2020;10(45):26777-91. doi: 10.1039/D0RA03491F, PMID 35515778.

Radtke M, Muller RH. Comparison of structural properties of solid lipid nanoparticles (SLN) versus other lipid particles. Proceedings of the International Symposium Control Rel Bioact Mater. 2000;27:309-10.

Ekambaram P, Abdul HS. Formulation and evaluation of solid lipid nanoparticles of ramipril. J Young Pharm. 2011 Jul;3(3):216-20. doi: 10.4103/0975-1483.83765, PMID 21897661, PMCID PMC3159275.

Soma D, Attari Z, Reddy MS, Damodaram A, Koteshwara KBG. Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies. Braz J Pharm Sci. 2017;53(1):e15012. doi: 10.1590/s2175-97902017000115012.

Suresh G, Manjunath K, Venkateswarlu V, Satyanarayana V. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. AAPS PharmSciTech. 2007 Mar 23;8(1):24. doi: 10.1208/pt0801024, PMID 17408223.

Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez Torres MDP, Acosta Torres LS. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16(1):71. doi: 10.1186/s12951-018-0392-8, PMID 30231877.

Prabhakaran E, Hasan A, Karunanidhi P. Solid lipid nanoparticles: a review. Vol. 2; 2011.

Katare OP, Raza K, Singh B, Dogra S. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors. Indian J Dermatol Venereol Leprol. 2010 Nov-Dec;76(6):612-21. doi: 10.4103/0378-6323.72451, PMID: 21079304.

Sivadasan D, Ramakrishnan K, Mahendran J, Ranganathan H, Karuppaiah A, Rahman H. Solid lipid nanoparticles: applications and prospects in cancer treatment. Int J Mol Sci. 2023;24(7):6199. doi: 10.3390/ijms24076199, PMID 37047172.

Bayon Cordero L, Alkorta I, Arana L. Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs. Nanomaterials (Basel). 2019 Mar 22;9(3):474. doi: 10.3390/nano9030474, PMID 30909401, PMCID PMC6474076.

Shah MK, Madan P, Lin S. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration. Pharm Dev Technol. 2014;19(4):475-85. doi: 10.3109/10837450.2013.795169, PMID 23697916.

Kristl J, Teskac K, Grabnar PA. Current view on nanosized solid lipid carriers for drug delivery to the skin. J Biomed Nanotechnol. 2010 Oct;6(5):529-42. PMID: 21329046.

Krishnatreyya H, Dey S, Pal P, Das PJ, Sharma VK, Mazumder B. Piroxicam loaded solid lipid nanoparticles (SLNs): potential for topical delivery. Indian J Pharm Educ Res. 2019;53(2S):s82-92. doi: 10.5530/ijper.53.2s.52.

Mahajan A, Kaur S, Kaur S. Design, formulation, and characterization of stearic acid-based solid lipid nanoparticles of candesartan cilexetil to augment its oral bioavailability. Asian J Pharm Clin Res. 2018;11(4):344-50. doi: 10.22159/ajpcr.2018.v11i4.23849.

Wissing SA, Müller RH. Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm. 2003;254(1):65-8. doi: 10.1016/s0378-5173(02)00684-1, PMID 12615411.

Abdelgawad NM, Hamza MY, Awad GAS. Topical and systemic dermal carriers for psoriasis. Int J Curr Pharm Res. 2016;8:4-9.

AKS, PA, PC. Formulation of solid lipid nanoparticles and their applications. JCPR. 2011;1(2):197-203. doi: 10.33786/JCPR.2011.v01i02.019.

Singh R. Preparation of solid lipid nanoparticles through various methods using different precursors. J Drug Delivery Ther. 2019;9(2):415-9. doi: 10.22270/jddt.v9i2.2461.

Ekambaram P, Abdul HS. Formulation and evaluation of solid lipid nanoparticles of ramipril. J Young Pharm. 2011 Jul;3(3):216-20. doi: 10.4103/0975-1483.83765, PMID 21897661, PMCID PMC3159275.

Sanzhakov MA, Ipatova OM, Torkhovskaia TI, Prozorovskii VN, Tikhonova EG, Druzhilovskaia OS, Medvedeva NV. Nanoparticles as drug delivery system for antituberculous drugs. Vestn Ross Akad Med Nauk. 2013;(8):37-44. PMID: 24340644.

Shinde AS, Lala RR. Mannose-anchored solid lipid nanoparticles loaded with atorvastatin calcium and vinpocetine as targeted therapy for breast cancer. Futur J Pharm Sci. 2023;9(1):81. doi: 10.1186/s43094-023-00531-y.

Abou Taleb HA, Fathalla Z, Naguib DM, Fatease AA, Abdelkader H. Chitosan/solid-lipid nanoparticles hybrid gels for vaginal delivery of estradiol for management of vaginal menopausal symptoms. Pharmaceuticals (Basel). 2023;16(9):1284. doi: 10.3390/ph16091284, PMID 37765092.

Jenning V, Mader K, Gohla SH. Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: a 1H-NMR study. Int J Pharm. 2000 Sep 15;205(1-2):15-21. doi: 10.1016/s0378-5173(00)00462-2, PMID 11000538.

Kushwaha AK, Vuddanda PR, Karunanidhi P, Singh SK, Singh S. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. BioMed Res Int. 2013. doi: 10.1155/2013/584549, PMID 24228255.

Parvez S, Yadagiri G, Gedda MR, Singh A, Singh OP, Verma A. Modified solid lipid nanoparticles encapsulated with amphotericin B and paromomycin: an effective oral combination against experimental murine visceral leishmaniasis. Sci Rep. 2020;10(1):12243. doi: 10.1038/s41598-020-69276-5, PMID 32699361.

Singh S, Dobhal AK, Jain A, Pandit JK, Chakraborty S. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine. Chem Pharm Bull (Tokyo). 2010;58(5):650-5. doi: 10.1248/cpb.58.650, PMID 20460791.

Kumar R, Singh A, Garg N. Acoustic cavitation-assisted formulation of solid lipid nanoparticles using different stabilizers. ACS Omega. 2019;4(8):13360-70. doi: 10.1021/acsomega.9b01532, PMID 31460464.

Qushawy M, Nasr A. Solid lipid nanoparticles (slns) as nano drug delivery carriers: preparation, characterization and application. Int J App Pharm. 2020;12(1):1-9. doi: 10.22159/ijap.2020v12i1.35312.

Aljaeid BM, Hosny KM. Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity. Int J Nanomedicine. 2016;11:441-7. doi: 10.2147/IJN.S100625, PMID 26869787.

Rawat PK, Tyagi CK, Shah SK, Pandey AK. Formulation, characterization and in vitro evaluation of famciclovir loaded solid lipid nanoparticles for improved oral absorption. J Pharm Res Int. 2020;32(29):1-17. doi: 10.9734/jpri/2020/v32i2930879.

Bhalekar M, Upadhaya P, Madgulkar A. Formulation and characterization of solid lipid nanoparticles for an anti-retroviral drug Darunavir. Appl Nanosci. 2017;7(1-2):47-57. doi: 10.1007/s13204-017-0547-1.

Mishra SK, Bhardwaj P, Tripathi A, Gupta R, Dudhe R, Patil PR. Development and characterization of solid lipid nanoparticles of aceclofenac by microemulsion technique using lecithin, pleuronic F-68, and sodium glycocholate. Journal of Advanced Scientific Research. 2022;3Suppl 7:207-12.

Shah J, Patel S, Bhairy S, Hirlekar R. Formulation optimization, characterization and in vitro anti-cancer activity of curcumin loaded nanostructured lipid carriers. Int J Curr Pharm Sci. 2022;14:31-43. doi: 10.22159/ijcpr.2022v14i1.44110.

Shrivastava S, Kaur CD. Fabrication of mebendazole loaded solid lipid nanoparticles: formulation, optimization, characterization, stabilization, and in vitro evaluation. IJPSDR. 2022;14:262-8. doi: 10.25004/IJPSDR.2022.140217.

Yallavula J, Mandava K, Madhav V. Design and evaluation of topical gel containing solid-lipid nanoparticles loaded with luliconazole. Int J Pharm Res Technol (IJPRT). 2023;13(2):52-64. doi: 10.31838/ijprt/13.02.07.

Shinde AS, Lala RR. Mannose-anchored solid lipid nanoparticles loaded with atorvastatin calcium and vinpocetine as targeted therapy for breast cancer. Futur J Pharm Sci. 2023;9(1):81. doi: 10.1186/s43094-023-00531-y.

Chen YJ, Jin RX, Zhou YQ, Zeng J, Zhang H, Feng QR. Preparation of solid lipid nanoparticles loaded with Xionggui powder-supercritical carbon dioxide fluid extraction and their evaluation in vitro release. Zhongguo Zhong Yao Za Zhi. 2006;31(5):376-9. PMID 16711418.

Jenning V, Gysler A, Schafer Korting M, Gohla SH. Vitamin a loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm. 2000;49(3):211-8. doi: 10.1016/s0939-6411(99)00075-2, PMID 10799811.

Pandey R, Sharma S, Khuller GK. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis (Edinb). 2005;85(5-6):415-20. doi: 10.1016/j.tube.2005.08.009, PMID 16256437.

Carbone C, Cupri S, Leonardi A, Puglisi G, Pignatello R. Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization. Pharm Pat Anal. 2013 Sep;2(5):665-77. doi: 10.4155/ppa.13.43, PMID: 24237173.

Santos Magalhaes NS, Mosqueira VC. Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):560-75. doi: 10.1016/j.addr.2009.11.024, PMID: 19914313.

Singh S, Chaturvedi P, Jain SK. Development and performance evaluation of tumor targeting potential of folate spacer functionalized solid lipid nanoparticles. Asian J Pharm Clin Res. 2021;14(6):141-7. doi: 10.22159/ajpcr.2021.v14i6.40968.

Shenoy VS, Vijay IK, Murthy RS. Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles. J Pharm Pharmacol. 2005 Apr;57(4):411-22. doi: 10.1211/0022357055894, PMID: 15831200.

Bhosale RR, Janugade BU, Chavan DD, Thorat VM. Current perspectives on applications of nanoparticles for cancer management. Int J Pharm Pharm Sci. 2023;15(11):1-10. doi: 10.22159/ijpps.2023v15i11.49319.

Attama AA. SLN, NLC, LDC: state of the art in drug and active delivery. Recent Pat Drug Deliv Formul. 2011 Sep;5(3):178-87. doi: 10.2174/187221111797200524, PMID: 21834777.

Estella Hermoso de Mendoza A, Campanero MA, Mollinedo F, Blanco Prieto MJ. Lipid nanomedicines for anticancer drug therapy. J Biomed Nanotechnol. 2009 Aug;5(4):323-43. doi: 10.1166/jbn.2009.1042, PMID: 20055079.

Chidambaram M, Manavalan R, Kathiresan K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci. 2011;14(1):67-77. doi: 10.18433/j30c7d, PMID: 21501554.

Plaza Oliver M, Santander Ortega MJ, Lozano MV. Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv Transl Res. 2021;11(2):471-97. doi: 10.1007/s13346-021-00908-7, PMID 33528830.

Mishra V, Bansal KK, Verma A, Yadav N, Thakur S, Sudhakar K. Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics. 2018 Oct 18;10(4):191. doi: 10.3390/pharmaceutics10040191, PMID 30340327, PMCID PMC6321253.

Sharma S, Goel V, Kaur P, Gadhave K, Garg N, Das Singla L. Targeted drug delivery using beeswax-derived albendazole-loaded solid lipid nanoparticles in Haemonchus contortus, an albendazole-tolerant nematode. Exp Parasitol. 2023 Oct;253:108593. doi: 10.1016/j.exppara.2023.108593, PMID 37595879.

Maiti D, Naseeruddin Inamdar M, Almuqbil M, Suresh S, Mohammed Basheeruddin Asdaq S, Alshehri S. Evaluation of solid-lipid nanoparticles formulation of methotrexate for anti-psoriatic activity. Saudi Pharm J. 2023;31(6):834-44. doi: 10.1016/j.jsps.2023.04.007, PMID 37228325.

Granja A, Lima Sousa R, Alves CG, de Melo Diogo D, Nunes C, Sousa CT. Multifunctional targeted solid lipid nanoparticles for combined photothermal therapy and chemotherapy of breast cancer. Biomater Adv. 2023 Aug;151:213443. doi: 10.1016/j.bioadv.2023.213443, PMID 37146526.

Liang Z, Zhang Z, Lu P, Yang J, Han L, Liu S. The effect of charges on the corneal penetration of solid lipid nanoparticles loaded econazole after topical administration in rabbits. Eur J Pharm Sci. 2023 Aug 1;187:106494. doi: 10.1016/j.ejps.2023.106494, PMID 37315870.

Fogolari O, Leimann FV, Ineu RP, Rudy M, Ludwig AF, Salles FM. Progesterone-loaded solid lipid nanoparticles for use in the regulation of the estrous cycle in female rats. J Drug Deliv Sci Technol. 2023 Oct;88:104954. doi: 10.1016/j.jddst.2023.104954.

Abou Taleb HA, Fathalla Z, Naguib DM, Fatease AA, Abdelkader H. Chitosan/solid-lipid nanoparticles hybrid gels for vaginal delivery of estradiol for management of vaginal menopausal symptoms. Pharmaceuticals (Basel). 2023;16(9):1284. doi: 10.3390/ph16091284, PMID 37765092.

Mo K, Kim A, Choe S, Shin M, Yoon H. Overview of solid lipid nanoparticles in breast cancer therapy. Pharmaceutics. 2023;15(8):2065. doi: 10.3390/pharmaceutics15082065, PMID 37631279.

Satyanarayana SD, Abu Lila AS, Moin A, Moglad EH, Khafagy ES, Alotaibi HF. Ocular delivery of bimatoprost-loaded solid lipid nanoparticles for effective management of glaucoma. Pharmaceuticals (Basel). 2023;16(7):1001. doi: 10.3390/ph16071001, PMID 37513913.

Subhan MA, Filipczak N, Torchilin VP. Advances with lipid-based nanosystems for siRNA delivery to breast cancers. Pharmaceuticals (Basel). 2023;16(7):970. doi: 10.3390/ph16070970, PMID 37513882.

Viegas C, Patricio AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review. Pharmaceutics. 2023;15(6):1593. doi: 10.3390/pharmaceutics15061593, PMID 37376042.

Li S, Chen J, Liu Y, Zheng Q, Tan W, Feng X. Application of cinnamaldehyde solid lipid nanoparticles in strawberry preservation. Horticulturae. 2023;9(5):607. doi: 10.3390/horticulturae9050607.

Guven E. Lipid-based nanoparticles in the treatment of erectile dysfunction. Int J Impot Res. 2020;32(6):578-86. doi: 10.1038/s41443-020-0235-7, PMID 32005938.

Abd El-Halim SM, Abdelbary GA, Amin MM, Zakaria MY, Shamsel Din HA, Ibrahim AB. Stabilized oral nanostructured lipid carriers of adefovir dipivoxil as a potential liver targeting: estimation of liver function panel and uptake following intravenous injection of radioiodinated indicator. Daru. 2020;28(2):517-32. doi: 10.1007/s40199-020-00355-8, PMID 32564282.

Dudhipala N, Veerabrahma Kishan. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Drug Deliv. 2016;23(2):395-404. doi: 10.3109/10717544.2014.914986, PMID 24865287.

Tzanova MM, Hagesaether E, Tho I. Solid lipid nanoparticle-loaded mucoadhesive buccal films–critical quality attributes and in vitro safety & efficacy. Int J Pharm. 2021 Jan;592:120100. doi: 10.1016/j.ijpharm.2020.120100, PMID 33227374.

Santonocito D, Campisi A, Pellitteri R, Sposito G, Basilicata MG, Aquino G. Lipid nanoparticles loading steroidal alkaloids of tomatoes affect neuroblastoma cell viability in an in vitro model. Pharmaceutics. 2023;15(11):2573. doi: 10.3390/pharmaceutics15112573, PMID 38004552.

Wang B, Wu K, Liu R, Huang Y, Chang Z, Gao Y. Phyllanthi tannin loaded solid lipid nanoparticles for lung cancer therapy: preparation, characterization, pharmacodynamics and safety evaluation. Molecules. 2023;28(21):7399. doi: 10.3390/molecules28217399, PMID 37959818.

Aljuffali IA, Anwer MK, Ahmed MM, Alalaiwe A, Aldawsari MF, Fatima F. Development of gefitinib-loaded solid lipid nanoparticles for the treatment of breast cancer: physicochemical evaluation, stability, and anticancer activity in breast cancer (MCF-7) cells. Pharmaceuticals (Basel). 2023;16(11):1549. doi: 10.3390/ph16111549, PMID 38004415.

Fatima F, Aleemuddin M, Ahmed MM, Anwer MK, Aldawsari MF, Soliman GA. Design and evaluation of solid lipid nanoparticles loaded topical gels: repurpose of fluoxetine in diabetic wound healing. Gels. 2022;9(1):21. doi: 10.3390/gels9010021, PMID 36661789.

Asif AH, Desu PK, Alavala RR, Rao GSNK, Sreeharsha N, Meravanige G. Development, statistical optimization and characterization of fluvastatin loaded solid lipid nanoparticles: a 32 factorial design approach. Pharmaceutics. 2022;14(3):584. doi: 10.3390/pharmaceutics14030584, PMID 35335960.

Akel H, Csoka I, Ambrus R, Bocsik A, Grof I, Meszaros M. In vitro comparative study of solid lipid and PLGA nanoparticles designed to facilitate nose-to-brain delivery of insulin. Int J Mol Sci. 2021;22(24):13258. doi: 10.3390/ijms222413258, PMID 34948054.

Tulbah AS, Lee WH. Physicochemical characteristics and in vitro toxicity/anti-SARS-CoV-2 activity of favipiravir solid lipid nanoparticles (SLNs). Pharmaceuticals (Basel). 2021;14(10):1059. doi: 10.3390/ph14101059, PMID 34681283.

Nair AB, Shah J, Al-Dhubiab BE, Jacob S, Patel SS, Venugopala KN. Clarithromycin solid lipid nanoparticles for topical ocular therapy: optimization, evaluation and in vivo studies. Pharmaceutics. 2021;13(4):523. doi: 10.3390/pharmaceutics13040523, PMID 33918870.

Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine. 2007;2(3):289-300. PMID 18019829, PMCID PMC2676658.

Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev. 2007 Jul 10;59(6):478-90. doi: 10.1016/j.addr.2007.04.007, PMID: 17543416.

Nair AB, Shah J, Al-Dhubiab BE, Jacob S, Patel SS, Venugopala KN. Clarithromycin solid lipid nanoparticles for topical ocular therapy: optimization, evaluation and in vivo studies. Pharmaceutics. 2021;13(4):523. doi: 10.3390/pharmaceutics13040523, PMID 33918870.

Pathak K, Keshri L, Shah M. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics. Crit Rev Ther Drug Carrier Syst. 2011;28(4):357-93. doi: 10.1615/critrevtherdrugcarriersyst.v28.i4.20, PMID: 21967401.

Hajj Ali H, Michaux F, Khanji AN, Jasniewski J, Linder M. Chitosan-shea butter solid nanoparticles assemblies for the preparation of a novel nanoparticles in microparticles system containing curcumin. Colloids Surf A Physicochem Eng Aspects. 2018;553:359-67. doi: 10.1016/j.colsurfa.2018.05.075.

Mohammadi Samani S, Zojaji S, Entezar Almahdi E. Piroxicam loaded solid lipid nanoparticles for topical delivery: preparation, characterization and in vitro permeation assessment. J Drug Deliv Sci Technol. 2018;47(Oct):427-33. doi: 10.1016/j.jddst.2018.07.015.

Kim JK, Park JS, Kim CK. Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. Int J Pharm. 2010;383(1-2, Jan):209-15. doi: 10.1016/j.ijpharm.2009.09.008, PMID 19747966.

Trombino S, Russo R, Mellace S, Varano GP, Lagana AS, Marcucci F. Solid lipid nanoparticles made of trehalose monooleate for cyclosporin-a topic release. J Drug Deliv Sci Technol. 2019;49:563-9. doi: 10.1016/j.jddst.2018.12.026.

Jaafar Maalej C, Elaissari A, Fessi H. Lipid-based carriers: manufacturing and applications for pulmonary route. Expert Opin Drug Deliv. 2012 Sep;9(9):1111-27. doi: 10.1517/17425247.2012.702751, PMID: 22724618.

Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004 Jun 18;278(1):71-7. doi: 10.1016/j.ijpharm.2004.02.032, PMID 15158950.

Kang KW, Chun MK, Kim O, Subedi RK, Ahn SG, Yoon JH. Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy. Nanomedicine. 2010 Apr;6(2):210-3. doi: 10.1016/j.nano.2009.12.006, PMID 20060074.

Aji Alex MR, Chacko AJ, Jose S, Souto EB. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci. 2011 Jan 18;42(1-2):11-8. doi: 10.1016/j.ejps.2010.10.002, PMID 20971188.

Moutinho CG, Matos CM, Teixeira JA, Balcao VM. Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art. J Drug Target. 2012 Feb;20(2):114-41. doi: 10.3109/1061186X.2011.628397, PMID: 22023555.

Guney G, Kutlu HM, Genç L. Preparation and characterization of ascorbic acid loaded solid lipid nanoparticles and investigation of their apoptotic effects. Colloids Surf B Biointerfaces. 2014 Sep 1;121:270-80. doi: 10.1016/j.colsurfb.2014.05.008, PMID 24985762.

Zhang Y, Li Z, Zhang K, Yang G, Wang Z, Zhao J. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles. Int J Pharm. 2016 Sep 10;511(1):57-64. doi: 10.1016/j.ijpharm.2016.06.131, PMID 27374194.

Shah B, Khunt D, Bhatt H, Misra M, Padh H. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: effect on formulation and characterization parameters. Eur J Pharm Sci. 2015;78:54-66. doi: 10.1016/j.ejps.2015.07.002, PMID 26143262.

Sathya S, Shanmuganathan B, Manirathinam G, Ruckmani K, Devi KP. α-Bisabolol loaded solid lipid nanoparticles attenuates Aβ aggregation and protects Neuro-2a cells from Aβ induced neurotoxicity. J Mol Liq. 2018;264:431-41. doi: 10.1016/j.molliq.2018.05.075.

Imam SS. Nanoparticles: the future of drug delivery. Int J Curr Pharm Sci. 2023;15(6):8-15. doi: 10.22159/ijcpr.2023v15i6.3076.